Health Care Equipment & Supplies · Nasdaq
IDXXIdexx Laboratories Inc
- Last close
- $704.23 +0.9%
- 52-week range
- $500.61 to $769.98
- Market cap
- $55.5B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own 10 years
Below its 10-year median on 3 of 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 47.5x
- Earnings yield
- 2.1%
- Price / sales
- 11.9x
- Price / book
- 29.7x
- Price / operating cash flow
- 39.1x
- EV / EBITDA
- 33.4x
- EV / sales
- 11.9x
- Free cash flow yield
- 2.4%
Profitability
- Gross margin
- 62.7%
- Operating margin
- 32.3%
- Net margin
- 25.4%
- Return on equity
- 63.2%
- Return on capital
- 53.6%
Growth per year
- Revenue, 3 years
- +8.5%
- Revenue, 5 years
- +9.7%
- Revenue, 9 years
- +10.3%
- EPS, 3 years
- +17.7%
Balance sheet
- Cash and investments
- $198M
- Total debt
- $375M
- Net cash
- -$177M
- Debt / equity
- 0.20x
- Current ratio
- 1.19x
Shares and dividend
- Shares outstanding
- 78.8M
- Share count, 5 years
- -6.6%
- Beta, 1 year
- 0.82
- Dividend yield
- n/a
- Dividend per share, TTM
- n/a
- Payout ratio
- n/a
n/a: No dividend
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Where the revenue comes from
Product went from 57% to 59% of revenue in 3 years
Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.
| Product line | Revenue | Share | vs FY24 |
|---|---|---|---|
| Product | $2.54B | 59.0% | +13% |
| Services | $1.76B | 41.0% | +7% |
Health Care Equipment & Supplies peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | $188B | +10% | 13.8% | 40.4x | 3.9x | 60th percentile |
| DHR Danaher Corp | $164B | +6% | 20.4% | 38.1x | 6.4x | 65th percentile |
| ISRG Intuitive Surgical Inc | $154B | +20% | 28.4% | 53.7x | 13.3x | 48th percentile |
| MDT Medtronic plc | $132B | +10% | 18.1% | 25.3x | 3.5x | 20th percentile |
| SYK Stryker Corp | $118B | +8% | 20.7% | 33.0x | 4.5x | 30th percentile |
| IDXX Idexx Laboratories Inc | $55.5B | +12% | 32.3% | 47.5x | 11.9x | 25th percentile |
The company
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Founded
- 1983
- Headquarters
- Westbrook, ME
- Fiscal year ends
- December
- Website
- idexx.com
What it does
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about IDXX.